Mark C. Schneyer

Companies

• Acadia PharmaceuticalsChief financial officer Dec 20, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APAcadia Pharmaceuticals ACAD67,828 shares²$1.3M at $19.61Aug 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 6, 2026Sold 9,292 shares at $29.34 of Acadia Pharmaceuticals²
• Aug 6, 2026Sold 5,000 shares at $29.00 of Acadia Pharmaceuticals²
• Aug 6, 2026Exercised options 14,292 shares at $17.84 of Acadia Pharmaceuticals²
• Aug 5, 2026Sold 5,849 shares at $29.00 of Acadia Pharmaceuticals²
• Aug 5, 2026Exercised options 5,849 shares at $17.84 of Acadia Pharmaceuticals²
• May 4, 2026Sold 3,506 shares at $21.79 of Acadia Pharmaceuticals³
• May 1, 2026Exercised options 6,815 shares of Acadia Pharmaceuticals³
• Apr 7, 2026Sold 2,709 shares at $22.20 of Acadia Pharmaceuticals⁴
• Apr 5, 2026Exercised options 5,276 shares of Acadia Pharmaceuticals⁴
• Mar 26, 2026Sold 37 shares at $21.72 of Acadia Pharmaceuticals⁵
• Mar 26, 2026Sold 3,171 shares at $21.65 of Acadia Pharmaceuticals⁵
• Mar 25, 2026Exercised options 6,178 shares of Acadia Pharmaceuticals⁵
• Mar 25, 2026Sold 4,177 shares at $21.47 of Acadia Pharmaceuticals⁵
• Mar 24, 2026Exercised options 8,138 shares of Acadia Pharmaceuticals⁵
• Nov 18, 2025Sold 10,262 shares at $23.69 of Acadia Pharmaceuticals⁶
• Nov 17, 2025Exercised options 9,913 shares of Acadia Pharmaceuticals⁶
• Nov 17, 2025Exercised options 9,913 shares of Acadia Pharmaceuticals⁶
• Sep 15, 2025Sold 3,498 shares at $23.65 of Acadia Pharmaceuticals⁷
• Sep 12, 2025Granted 6,815 shares of Acadia Pharmaceuticals⁷
• Aug 18, 2025Sold 22,000 shares at $25.18 of Acadia Pharmaceuticals⁸
• May 16, 2025Sold 2,000 shares at $25.00 of Acadia Pharmaceuticals⁹
• May 2, 2025Sold 3,498 shares at $14.60 of Acadia Pharmaceuticals¹⁰
• May 1, 2025Exercised options 6,815 shares of Acadia Pharmaceuticals¹⁰
• Apr 8, 2025Sold 2,708 shares at $14.82 of Acadia Pharmaceuticals¹¹
• Apr 5, 2025Exercised options 5,275 shares of Acadia Pharmaceuticals¹¹